Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rose Lee Bell"'
Autor:
Jeffrey C. Hageman, David A. Pegues, Carrie Jepson, Rose Lee Bell, Mary Guinan, Kevin W. Ward, Martin D. Cohen, Janet A. Hindler, Fred C. Tenover, Sigrid K. McAllister, Molly E. Kellum, Scott K. Fridkin
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 6, Pp 1023-1025 (2001)
In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested exc
Externí odkaz:
https://doaj.org/article/109604f000d94405b38dd7c123e20b57
Autor:
Sigrid K. McAllister, Scott K. Fridkin, Janet A. Hindler, Mary E. Guinan, Martin D. Cohen, Carrie Jepson, Kevin W. Ward, Rose Lee Bell, Fred C. Tenover, David A. Pegues, Jeffrey C. Hageman, Molly E. Kellum
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 6, Pp 1023-1025 (2001)
Emerging Infectious Diseases
Emerging Infectious Diseases
In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested exc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc0504632146ae746a69701576e1080d
https://doi.org/10.3201/eid0706.010618
https://doi.org/10.3201/eid0706.010618
Publikováno v:
Controlled Clinical Trials. 6:102-111
The close-out of clinical trials that end ahead of schedule often involves problems that differ from those of trials that end as planned. The Beta-Blocker Heart Attack Trial (BHAT), a double-blind study of 3837 post-myocardial infarction patients, wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa677c6417f75af9b9afeacff831abb
https://doi.org/10.1016/0197-2456(85)90115-1
https://doi.org/10.1016/0197-2456(85)90115-1
Publikováno v:
Controlled Clinical Trials. 6:89-101
Efforts were made in the Beta Blocker Heart Trial (BHAT), a double-blind study of 3837 post-MI patients, to enhance visit adherence, a measure of compliance that is not subjective and can be easily monitored. Of the required visits, 93.9% were comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba96efb6fdf345198095172876fcbdc
https://doi.org/10.1016/0197-2456(85)90114-x
https://doi.org/10.1016/0197-2456(85)90114-x
Autor:
E. O'Brian Smith, Rose Lee Bell
Publikováno v:
Controlled clinical trials. 3(1)
Based on a literature review, the value of clinical trials as a method for satisfying the objectives of a post-marketing drug surveillance (PMS) system is discussed. Although clinical trials serve an important role in this system, it is shown that ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77eb1636c2ce4ff8f78da2ac13a3345c
https://pubmed.ncbi.nlm.nih.gov/7067472
https://pubmed.ncbi.nlm.nih.gov/7067472